^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    pirotinib (KBP-5209)

    i
    Associations
    News

    Trials

    Company:
    Sihuan Pharmaceutical
    Drug class:
    EGFR inhibitor, HER2 inhibitor, HER4 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research (PYTHON) (NCT05885776)
    Phase 2
    Tianjin Medical University Cancer Institute and...
    Recruiting
    Last update posted :
    06/02/2023
    Initiation :
    09/13/2022
    Primary completion :
    03/30/2024
    Completion :
    09/30/2025
    HER-2
    |
    HER-2 positive
    |
    Herceptin (trastuzumab) • pirotinib (KBP-5209)